PortfoliosLab logo

Beam Therapeutics Inc. (BEAM)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Beam Therapeutics Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $16,331 for a total return of roughly 63.31%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
63.31%
22.82%
BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BEAM

Beam Therapeutics Inc.

Popular comparisons: BEAM vs. CRSP, BEAM vs. TWST, BEAM vs. SCHD

Return

Beam Therapeutics Inc. had a return of -21.71% year-to-date (YTD) and -48.49% in the last 12 months. Over the past 10 years, Beam Therapeutics Inc. had an annualized return of 16.87%, outperforming the S&P 500 benchmark which had an annualized return of 6.75%.


PeriodReturnBenchmark
1 month-23.91%3.51%
Year-To-Date-21.71%7.03%
6 months-35.54%12.88%
1 year-48.49%-10.71%
5 years (annualized)16.87%6.75%
10 years (annualized)16.87%6.75%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202311.10%-7.39%
2022-12.75%-7.51%4.83%-15.33%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Beam Therapeutics Inc. Sharpe ratio is -0.58. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.58
-0.46
BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)

Dividend History


Beam Therapeutics Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2023FebruaryMarch
-77.08%
-14.33%
BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Beam Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Beam Therapeutics Inc. is 77.65%, recorded on Jun 13, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-77.65%Jul 2, 2021239Jun 13, 2022
-54.42%Feb 14, 202021Mar 16, 202077Jul 6, 202098
-46.9%Feb 9, 202163May 10, 202136Jun 30, 202199
-37.83%Jul 10, 202017Aug 3, 202052Oct 15, 202069
-20.59%Jan 19, 20216Jan 26, 20218Feb 5, 202114
-14.63%Dec 29, 20203Dec 31, 20204Jan 7, 20217
-14.07%Dec 15, 20203Dec 17, 20202Dec 21, 20205
-11%Oct 28, 20205Nov 3, 202010Nov 17, 202015
-9.81%Oct 16, 20204Oct 21, 20201Oct 22, 20205
-7.47%Jan 11, 20211Jan 11, 20213Jan 14, 20214

Volatility Chart

Current Beam Therapeutics Inc. volatility is 39.23%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%NovemberDecember2023FebruaryMarch
39.23%
15.42%
BEAM (Beam Therapeutics Inc.)
Benchmark (^GSPC)